SCHEMBL26880963

SCHEMBL26880963

Cc1c2c(c3scnc3c1C(C)(C)C)OC(C)(C(C)(C)C)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23823121 0.67 — —
SCHEMBL17755568 0.60 KDM4E (0.33) —
SCHEMBL18876126 0.57 KDM4E (0.31) —
SCHEMBL12157070 0.55 ADORA2A (0.33) —
SCHEMBL14282452 0.53 — —
SCHEMBL15339525 0.53 PDPK1 (0.32) —
SCHEMBL24284147 0.53 KDM4E (0.32) —
SCHEMBL8581086 0.52 PI4KA (0.32) —
SCHEMBL8737066 0.52 — —
SCHEMBL18876081 0.52 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
Send feedback